• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

作者信息

Siragy Helmy M

机构信息

Department of Internal Medicine, University of Virginia Health System, Charlottesville, VA 22908, USA.

出版信息

Curr Hypertens Rep. 2003 Aug;5(4):293-4. doi: 10.1007/s11906-003-0036-7.

DOI:10.1007/s11906-003-0036-7
PMID:12844462
Abstract
摘要

相似文献

1
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Curr Hypertens Rep. 2003 Aug;5(4):293-4. doi: 10.1007/s11906-003-0036-7.
2
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).血管紧张素转换酶抑制剂或钙通道阻滞剂与利尿剂治疗高危高血压患者的肾脏转归：抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）报告
Arch Intern Med. 2005 Apr 25;165(8):936-46. doi: 10.1001/archinte.165.8.936.
3
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).高危高血压患者随机接受血管紧张素转换酶抑制剂或钙通道阻滞剂与利尿剂治疗的主要结局：抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）
JAMA. 2002 Dec 18;288(23):2981-97. doi: 10.1001/jama.288.23.2981.
4
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.利尿剂在预防心力衰竭中的作用：预防心脏病发作的抗高血压和降脂治疗试验
Circulation. 2006 May 9;113(18):2201-10. doi: 10.1161/CIRCULATIONAHA.105.544031. Epub 2006 May 1.
5
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.纤维蛋白原β基因变体-455G>A对心血管疾病、终末期肾病及死亡率的降压药物遗传学效应：基因高血压治疗（GenHAT）研究
Pharmacogenet Genomics. 2009 Jun;19(6):415-21. doi: 10.1097/FPC.0b013e32832a8e81.
6
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).随机接受3种不同类别降压治疗的老年非糖尿病成年人的空腹血糖水平与新发糖尿病：抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）的报告
Arch Intern Med. 2006 Nov 13;166(20):2191-201. doi: 10.1001/archinte.166.20.2191.
7
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.使用氯噻酮、氨氯地平和赖诺普利治疗的高血压黑人和非黑人患者的治疗结果。
JAMA. 2005 Apr 6;293(13):1595-608. doi: 10.1001/jama.293.13.1595.
8
Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT.在抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）中，随机接受利尿剂、血管紧张素转换酶抑制剂或钙通道阻滞剂治疗的患者发生住院胃肠道出血的风险。
J Clin Hypertens (Greenwich). 2013 Nov;15(11):825-32. doi: 10.1111/jch.12180. Epub 2013 Aug 7.
9
[ALLHAT trial--antithesis to the overuse of vasodilating antihypertensive drugs].[抗高血压和降脂治疗预防心脏病发作试验——反对过度使用血管舒张性抗高血压药物]
Nihon Rinsho. 2004 Mar;62 Suppl 3:648-53.
10
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).2型糖尿病、空腹血糖受损及血糖正常者降压治疗的临床结局：抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）
Arch Intern Med. 2005 Jun 27;165(12):1401-9. doi: 10.1001/archinte.165.12.1401.

引用本文的文献

1
Unobserved automated office BP is similar to other clinic BP measurements: A prospective randomized study.未观察到的自动诊室血压与其他诊室血压测量值相似：一项前瞻性随机研究。
J Clin Hypertens (Greenwich). 2018 Oct;20(10):1411-1416. doi: 10.1111/jch.13371. Epub 2018 Oct 1.
2
Modifiable lifestyle risk factors for stroke among a high risk hypertensive population in Greater Kampala, Uganda; a cross-sectional study.乌干达坎帕拉市高危高血压人群中可改变的中风生活方式风险因素；一项横断面研究。
BMC Res Notes. 2017 Dec 4;10(1):675. doi: 10.1186/s13104-017-3009-7.
3
Short-term hypertension management in community is associated with long-term risk of stroke and total death in China: A community controlled trial.

本文引用的文献

1
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.血管紧张素转换酶抑制剂雷米普利对高危患者心血管事件的影响。
N Engl J Med. 2000 Jan 20;342(3):145-53. doi: 10.1056/NEJM200001203420301.
2
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.与用作一线药物的抗高血压疗法相关的健康结局。一项系统评价和荟萃分析。
JAMA. 1997 Mar 5;277(9):739-45.
3
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
中国社区短期高血压管理与中风及全因死亡的长期风险相关：一项社区对照试验。
Medicine (Baltimore). 2016 Nov;95(48):e5245. doi: 10.1097/MD.0000000000005245.
4
Comparison of electrophysiological effects of calcium channel blockers on cardiac repolarization.钙通道阻滞剂对心脏复极化电生理效应的比较。
Korean J Physiol Pharmacol. 2016 Jan;20(1):119-27. doi: 10.4196/kjpp.2016.20.1.119. Epub 2015 Dec 31.
5
Pharmacogenetics of antihypertensive drug response.抗高血压药物反应的药物遗传学
Curr Hypertens Rep. 2004 Feb;6(1):15-20. doi: 10.1007/s11906-004-0005-9.
血管紧张素转换酶抑制对糖尿病肾病的影响。协作研究组。
N Engl J Med. 1993 Nov 11;329(20):1456-62. doi: 10.1056/NEJM199311113292004.
4
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.硝苯地平。冠心病患者死亡率呈剂量相关增加。
Circulation. 1995 Sep 1;92(5):1326-31. doi: 10.1161/01.cir.92.5.1326.
5
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.依那普利对左心室射血分数降低的无症状患者死亡率及心力衰竭发生的影响。
N Engl J Med. 1992 Sep 3;327(10):685-91. doi: 10.1056/NEJM199209033271003.